{
    "eid": "2-s2.0-85099723203",
    "title": "Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2",
    "cover-date": "2021-01-07",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Plant Science",
            "@code": "1110",
            "@abbrev": "AGRI"
        }
    ],
    "keywords": [
        "ACE2-Fc fusion protein",
        "COVID-19",
        "molecular farming",
        "Nicotiana benthamiana",
        "plant-produced recombinant protein",
        "SARS-CoV-2"
    ],
    "authors": [
        "Konlavat Siriwattananon",
        "Suwimon Manopwisedjaroen",
        "Phongthon Kanjanasirirat",
        "Priyo Budi Purwono",
        "Kaewta Rattanapisit",
        "Balamurugan Shanmugaraj",
        "Duncan R. Smith",
        "Suparerk Borwornpinyo",
        "Arunee Thitithanyanont",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 33,
    "ref-count": 76,
    "ref-list": [
        "SARS-CoV-2 Vaccines: status report",
        "Plant molecular farming: opportunities and challenges",
        "Therapeutic recombinant protein production in plants: challenges and opportunities",
        "Transient expression systems in plants: potentialities and constraints",
        "Introduction to current and future protein therapeutics: a protein engineering perspective",
        "Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes",
        "Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants",
        "COVID-19 Outbreak: an overview",
        "Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor/immunoglobulin fusion protein",
        "Fc-fusion proteins: new developments and future perspectives",
        "Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody",
        "Middle East respiratory syndrome (MERS): emergence of a pathogenic human Coronavirus",
        "Commercial aspects of pharmaceutical protein production in plants",
        "Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus",
        "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. a first step in understanding SARS pathogenesis",
        "Coronavirus 2019-nCoV: a brief perspective from the front line",
        "Human coronavirus NL63 employs the Severe acute respiratory syndrome coronavirus receptor for cellular entry",
        "High-yield rapid production of hepatitis B surface antigen in plant leaf by a viral expression system",
        "Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats",
        "Lessons from SARS: a new potential therapy for acute respiratory distress syndrome (ARDS) with angiotensin converting enzyme 2 (ACE2)",
        "Angiotensin-converting enzyme 2 protects from severe acute lung failure",
        "Transient expression of hemagglutinin antigen from low pathogenic avian influenza A (H7N7) in Nicotiana benthamiana",
        "Plant biopharming of monoclonal antibodies",
        "Transient expression systems for plant-derived biopharmaceuticals",
        "Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge",
        "Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China",
        "Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters",
        "A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury",
        "Recent advances in (therapeutic protein) drug development",
        "The COVID-19 vaccine development landscape",
        "Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig",
        "Structure of SARS coronavirus spike receptor-binding domain complexed with receptor",
        "Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia",
        "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus",
        "Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation",
        "2019 novel coronavirus (2019-nCoV) outbreak: a new challenge",
        "Properties of coronavirus and SARS-CoV-2",
        "Engineering the plant secretory pathway for the production of next-generation pharmaceuticals",
        "The molecular biology of coronaviruses",
        "Potential of plants to produce recombinant protein products",
        "A classical swine fever virus E2 fusion protein produced in plants elicits a neutralizing humoral immune response in mice and pigs",
        "Prolonged activity of factor IX as a monomeric Fc fusion protein",
        "Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana",
        "Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients",
        "The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement",
        "SARS-CoV-2 and coronavirus disease 2019: what we know so far",
        "Plant-produced anti-enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection",
        "Structural and in vitro functional analyses of novel plant-produced anti-Human PD1 antibody",
        "Rapid and scalable production of functional anti-coronavirus monoclonal antibody CR3022 in plants",
        "Plant-produced recombinant Osteopontin-Fc fusion protein enhanced osteogenesis",
        "A perspective on the development of plant-made vaccines in the fight against Ebola virus",
        "Transient expressions of synthetic biology in plants",
        "Emergence of novel Coronavirus 2019-nCoV: need for rapid vaccine and biologics development",
        "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)",
        "Plant expression platform for the production of recombinant pharmaceutical proteins",
        "Molecular farming: production of drugs and vaccines in higher plants",
        "Plant molecular pharming for the treatment of chronic and infectious diseases",
        "Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents",
        "Cytokine storm intervention in the early stages of COVID-19 pneumonia",
        "Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR",
        "Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco",
        "Immunogenicity in humans of an edible vaccine for hepatitis B",
        "Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody",
        "Molecular farming in plants: host systems and expression technology",
        "Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12",
        "A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2",
        "Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension",
        "Severe COVID-19: a review of recent progress with a look toward the future",
        "Plants as factories for human pharmaceuticals: applications and challenges",
        "COVID-19 pathophysiology: a review",
        "Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target",
        "Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin",
        "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
        "Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Surabaya",
            "@id": "60069383",
            "affilname": "Universitas Airlangga",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069383",
            "affiliation-country": "Indonesia"
        }
    ],
    "funding": [
        "C2F",
        "Department of Disease Control",
        "Ministry of Public Health",
        "Second Century Fund",
        "Chulalongkorn University"
    ]
}